AustraliaEverlab closes an AU$65M Series A16 JunTrial milestone · SingaporePROMETHEUS advances to the XPRIZE Healthspan finals15 AprRegulatory · GlobalFDA approves oral orforglipron (Foundayo)1 AprGlobalInsilico Medicine lists on the Hong Kong Stock Exchange30 DecRegulatory · GlobalFDA approves oral semaglutide (Wegovy)6 DecAustraliaEverlab closes an AU$65M Series A16 JunTrial milestone · SingaporePROMETHEUS advances to the XPRIZE Healthspan finals15 AprRegulatory · GlobalFDA approves oral orforglipron (Foundayo)1 AprGlobalInsilico Medicine lists on the Hong Kong Stock Exchange30 DecRegulatory · GlobalFDA approves oral semaglutide (Wegovy)6 Dec
Today
Where to start today.
Person spotlight
Dr Adam Brown
Founder, Longevity Medicine Institute
Clinic of the day
Chi Longevity
Singapore · Singapore
Be the first to save this
Company watch
Unity Biotechnology
NASDAQ · NASDAQ:UBX
Fund watch
Brandon Capital
VC · >A$1B across 6 funds
Protocol primer
Rapamycin / mTOR inhibition
PreclinicalWhat to watch
No confirmed events in the near term. The calendar tracks every dated move.
More coverage
The rest of today’s briefing.
Category
Market
Regulatory · Global
FDA approves oral semaglutide (Wegovy)
6 DecGlobal
Insilico Medicine lists on the Hong Kong Stock Exchange
30 DecSingapore + Australia · Capital
Two rounds, one IPO: how Singapore and Australia are funding longevity in 2025 to 2026
29 JunAustralia
Everlab closes an AU$65M Series A
16 JunTrial milestone · Singapore
PROMETHEUS advances to the XPRIZE Healthspan finals
15 AprGlobal · Protocol
GLP-1s and healthspan: a 2026 reader’s primer
1 JulSingapore · Clinical
New trial to test precision geromedicine for healthy ageing
1 JulSingapore · Industry
NUS launches healthy longevity graduate certificate
1 JulSingapore · Industry
Can longevity be designed for everyone, not just the wealthy?
1 JulRegulatory · Global
FDA approves oral orforglipron (Foundayo)
1 AprCoverage
Science and lifestyle
Coverage
Capital and public markets
Coverage
Industry and regulation
Every claim traced to a named source and evidence-graded. See how at editorial standards, or the public corrections log.